-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Maintains Market Outperform on Progyny, Raises Price Target to $38

Benzinga·11/05/2026 14:37:41
Listen to the news
Citizens analyst Constantine Davides maintains Progyny (NASDAQ:PGNY) with a Market Outperform and raises the price target from $33 to $38.